Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01347866
Title Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | CAN

Facility Status City State Zip Country Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095-6984 United States Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
UCLA Medical Center Los Angeles California 90095 United States Details
UCLA Oncology Center Los Angeles California 90095 United States Details
Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica California 90404 United States Details
UCLA Santa Monica Hematology Oncology Santa Monica California 90404 United States Details
Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
University of Colorado Denver (CTRC) Aurora Colorado 80045 United States Details
University of Colorado Hospital Anschutz Inpatient Pavilion Aurora Colorado 80045 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Medical University of South Carolina, Hollings Cancer Center Charleston South Carolina 29425 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
MUSC, Investigational Drug Services Charleston South Carolina 29425 United States Details
MUSC Health East Cooper Mount Pleasant South Carolina 29464 United States Details
MUSC Specialty Care-North North Charleston South Carolina 29406 United States Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
Ospedale San Raffaele Milano 20132 Italy Details
Hospital General Vall d'Hebron Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field